Back to Articles Weight management

Foundayo vs. Wegovy pill: How the two weight loss tablets compare

Compare Foundayo and Wegovy tablets: how they work, available strengths, daily dosing and the food, water and timing instructions that differ.

Faceless lavender figure considering two tablet-routine illustrations at a peach table.

What is Foundayo?

Foundayo (orforglipron) is an oral, prescription-only medication designed to support weight management in adults when combined with a calorie-restricted diet and regular exercise.

What is Wegovy Pill?

Wegovy (semaglutide) is also available as an oral, prescription-only medication that has been designed to support weight management in adults combined with a calorie-restricted diet and regular exercise.

Both tablets, Foundayo and Wegovy, work by activating GLP-1 receptors.

As GLP-1 receptor agonists, both Foundayo and Wegovy replicate the effects of the naturally produced gut hormone GLP-1. When you eat, your gut secretes GLP-1 to slow stomach emptying, boost feelings of fullness, and enhance overall satiety. By imitating this process, both treatments activate regions in the brain that can help you feel satisfied more quickly and stay full for longer periods.

In what ways do Foundayo and Wegovy pills differ?

In addition to their primary mechanisms, Wegovy and Foundayo share some side effects. Since both treatments stimulate GLP-1 receptors, they share similar gastrointestinal side effects such as nausea, vomiting, diarrhoea, constipation, and bloating, which are particularly common when initiating therapy or increasing the dosage.

Your healthcare provider can guide you through some key differences between the two tablets, helping you select the option best aligned with your lifestyle and support long-term adherence.

The table below outlines how these two therapies compare:

Feature Wegovy Foundayo
Active Ingredient Semaglutide Orforglipron
Mechanism of Action GLP-1 agonist GLP-1 agonist
Method of Administration Oral Tablet Oral Tablet
Tablet strengths (not equivalent) 1.5mg, 4mg, 9mg, 25mg 0.8mg, 2.5mg, 5.5mg, 9mg, 14.5mg, 17.2mg
Dosing Frequency Once Daily Once Daily
Dosing Restrictions Given on an empty stomach after a recommended fasting period of at least 8 hours
Swallowed whole with a maximum of 120 mL of water
Wait at least 30 minutes after taking your dose before eating, drinking or taking other oral medications
Given any time of the day regardless of meals or drinks
Comparison of the daily tablet instructions for Wegovy and Foundayo.
Both are taken once daily, but their food, water and timing instructions differ.

So, which one is better: Wegovy tablets or Foundayo tablets?

Determining a clear winner is difficult, particularly because the direct, head-to-head ACHIEVE-3 trial compared orforglipron with oral semaglutide at diabetes doses rather than Wegovy 25 mg tablets. Individual preference plays a major role though. While some individuals may favor the greater flexibility of Foundayo's daily dosing, others may not mind the specific administration rules required for Wegovy tablets around their morning routine.

Your healthcare provider can guide you through these key differences, helping you select the option best aligned with your lifestyle and support long-term adherence.

References

  1. Foundayo 9 mg film-coated tablets — Summary of Product Characteristics
  2. Foundayo 0.8 mg film-coated tablets — Patient Information Leaflet
  3. Wegovy 1.5 mg tablets — Summary of Product Characteristics
  4. Wegovy 9 mg tablets — Patient Information Leaflet
  5. Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial

About the contributors

Author

Noor Altaleb

Pharmacist · MPharm · GPhC number: 2226427

Reviewer

Mustafa Razzak

Superintendent Pharmacist · MPharm · GPhC number: 2215506